Myocardial infarction (MI) — secondary prevention
- High-intensity statin + antiplatelet therapy
- Control BP, diabetes, smoking + activity
- Beta blocker if LV dysfunction/other indication
- ACEi/ARB for LV dysfunction/HTN/CKD
- DAPT duration depends on ACS/PCI/bleeding risk
- Cardiac rehab is high-value therapy
- Add LDL-lowering drugs if target unmet
Use at a glance
- High-intensity statin + antiplatelet therapy
Treatment options
- Control BP, diabetes, smoking + activity
- ACEi/ARB for LV dysfunction/HTN/CKD
- Cardiac rehab is high-value therapy
Choosing treatment
- Beta blocker if LV dysfunction/other indication
- Add LDL-lowering drugs if target unmet
Treatment selection
- DAPT duration depends on ACS/PCI/bleeding risk
Self-check
- What drug classes support MI secondary prevention?
High-intensity statin + antiplatelet therapy. - What determines DAPT duration after MI?
ACS/PCI and bleeding risk.
Drugs used for this (5)
All clinical uses · Open Myocardial infarction (MI) — secondary prevention in the interactive console ↗